Americus, GA – Today, Congressman Sanford D. Bishop, Jr. (GA-02) is proud to announce that the Administration for Community Living (ACL) / Administration on Aging (AOA) has awarded a grant of $962,620 to the Rosalynn Carter Institute for Caregiving at Georgia Southwestern State University for their project, the Specialized Supportive Services Project through the Alzheimer’s Disease Initiative. The project’s goal is to address service gaps and strengthen existing services through the development and delivery of an evidence-based curriculum focused on behavioral symptom management.
“The Rosalynn Carter Institute for Caregiving and Georgia Southwestern State University has been a leader in the treatment of family members impacted by Alzheimer’s Disease,” said Congressman Bishop. “It is truly important that we improve our understanding of how to care for individuals afflicted with Alzheimer’s Disease as our population ages.”
“The project provides evidence based training for caregivers, both family and direct care workers. It is challenging to manage dementia behaviors that are a part of the Alzheimer’s disease, especially for those who are caring for people troubled by the symptoms. The goal of our project is to address service gaps and strengthen the existing service for people with dementia in Georgia.” said Dr. Leisa Easom, Principal Investigator of the Alzheimer’s Disease Initiative: Specialized Supportive Services Project at the Rosalynn Carter Institute for Caregiving at Georgia Southwestern State University.
The grant will be used to develop the Dealing with Dementia Behaviors (DDB) Caregiver Manual and accompanying training curriculum, which will disseminated to direct care workers, persons with Alzheimer’s disease and Related Dementia (ADRD) living alone, those with developmental disabilities, and family caregivers. Furthermore, the project will educate and collaborate with Area Agencies on Aging, family caregivers, volunteers, and direct care work force who deal with individuals struggling with disorders exhibiting a decline in brain function such as Alzheimer’s disease.
###